This study investigates advanced pancreatic cancer. The purpose of this study is to compare two treatments for this condition in patients who have already received treatment with gemcitabine.
The study evaluates the safety and effectiveness of two treatments. It looks at how well patients tolerate these treatments and any side effects they may experience.
- Who can participate: Adults over 20 years with advanced pancreatic cancer can join if they have been previously treated with gemcitabine and have a good performance status.
- Study details: Participants will receive either the NaliCap treatment or the NAPOLI treatment.